Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles.
about
RNA dimerization defect in a Rous sarcoma virus matrix mutant.The human polycomb group EED protein interacts with the integrase of human immunodeficiency virus type 1Characterization of a novel type of HIV-1 particle assembly inhibitor using a quantitative luciferase-Vpr packaging-based assayThe inhibition of assembly of HIV-1 virus-like particles by 3-O-(3',3'-dimethylsuccinyl) betulinic acid (DSB) is counteracted by Vif and requires its Zinc-binding domain.Human Polycomb group EED protein negatively affects HIV-1 assembly and release.Baculovirus display of single chain antibody (scFv) using a novel signal peptideAnalysis of the assembly function of the human immunodeficiency virus type 1 gag protein nucleocapsid domain.Roles of matrix, p2, and N-terminal myristoylation in human immunodeficiency virus type 1 Gag assembly.Basic residues in human immunodeficiency virus type 1 nucleocapsid promote virion assembly via interaction with RNA.Rescue of multiple viral functions by a second-site suppressor of a human immunodeficiency virus type 1 nucleocapsid mutation.Human immunodeficiency virus type 1 virion density is not determined by nucleocapsid basic residuesHuman immunodeficiency virus type 1 Gag polyprotein multimerization requires the nucleocapsid domain and RNA and is promoted by the capsid-dimer interface and the basic region of matrix protein.Organization of immature human immunodeficiency virus type 1Multimerization of human immunodeficiency virus type 1 Gag promotes its localization to barges, raft-like membrane microdomainsAntiviral activity of recombinant ankyrin targeted to the capsid domain of HIV-1 Gag polyprotein.Self-assembly in vitro of purified CA-NC proteins from Rous sarcoma virus and human immunodeficiency virus type 1.Elimination of protease activity restores efficient virion production to a human immunodeficiency virus type 1 nucleocapsid deletion mutant.Synthesis and assembly of retrovirus Gag precursors into immature capsids in vitro.Effects of nucleocapsid mutations on human immunodeficiency virus assembly and RNA encapsidationStructural and functional determinants in adenovirus type 2 penton base recombinant protein.Defect of human immunodeficiency virus type 2 Gag assembly in Saccharomyces cerevisiae.Human immunodeficiency virus type 1 Vif protein binds to the Pr55Gag precursor.A novel platform for virus-like particle-display of flaviviral envelope domain III: induction of Dengue and West Nile virus neutralizing antibodiesActive foamy virus proteinase is essential for virus infectivity but not for formation of a Pol polyprotein.Tyrosine kinase-dependent release of an adenovirus preterminal protein complex from the nuclear matrixRole of the N-terminal zinc finger of human immunodeficiency virus type 1 nucleocapsid protein in virus structure and replication.Murine leukemia virus particle assembly quantitated by fluorescence microscopy: role of Gag-Gag interactions and membrane association
P2860
Q24524289-A894BAC1-8B58-4873-B61A-AA434227139CQ24649552-26853110-9EC8-4404-B4E0-66800B73F36BQ28477791-E663A020-DFA2-412C-ACBB-F4098641E907Q30440445-8558443B-93BF-4C1F-B821-98E909FB9566Q30444754-18DB402B-7072-4DD6-9EC1-FF3B47307929Q33751786-77C7EFC5-C051-4ED9-B489-8BD2F8EE0EFCQ33782263-2DD121F6-D9D1-4797-8009-DDECF84CAC0EQ33794223-9DE816EE-51A7-49B6-A95A-9D6A3B4B2B97Q33800960-4B34D4E9-D836-4124-AD5F-7D0AA925E9C4Q33803814-5FB8E51D-AC5A-49AE-A6B2-BCF0CB49AFA9Q33808429-1EC1355C-0B5E-440D-9F10-FE814484EF53Q33820522-2D28D7C8-6796-4466-8BFF-0022A251374AQ33835481-A8E7B4AC-A455-4663-B66A-3B065F817B09Q33853532-22F5FC9C-A55C-4F51-BDC5-EEE37B96E9A6Q34163977-74F0F37C-9C66-44BA-9315-C7E0DB16218DQ34304675-F4C3278F-AE27-4013-9ED6-716C4AFAB85BQ34976852-143F99A0-2EBA-498B-930A-2D3553DA09AEQ35861388-45282CAE-AE36-46B9-81AB-EB585CC568F3Q35891833-85086FFD-A448-491F-BF4E-9ED4EB8C27A7Q35898849-3D64DC93-C269-4A36-982B-09EEF8687280Q36098951-DAC4DCBD-BA0D-4CF7-956D-128EF1F174A7Q36548864-2DEC2398-14BD-4652-89E7-786E5DEEB16AQ36889041-C18B5F2A-430C-46F2-B406-D715644CDBE4Q38290008-27CCDB43-8FF1-41F5-9ADC-65BE64943B4CQ38358550-61B69F63-1FF1-4285-A65C-9A552A865FC2Q39578721-B351B5DA-D7F9-4BBE-BCAE-982E2A222439Q40011798-CDBA6AAB-BE4C-4BB7-8189-1D862459635B
P2860
Sequence requirements for encapsidation of deletion mutants and chimeras of human immunodeficiency virus type 1 Gag precursor into retrovirus-like particles.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Sequence requirements for enca ...... nto retrovirus-like particles.
@ast
Sequence requirements for enca ...... nto retrovirus-like particles.
@en
type
label
Sequence requirements for enca ...... nto retrovirus-like particles.
@ast
Sequence requirements for enca ...... nto retrovirus-like particles.
@en
prefLabel
Sequence requirements for enca ...... nto retrovirus-like particles.
@ast
Sequence requirements for enca ...... nto retrovirus-like particles.
@en
P2093
P2860
P1433
P1476
Sequence requirements for enca ...... nto retrovirus-like particles.
@en
P2093
P2860
P304
P407
P577
1995-04-01T00:00:00Z